2020 CRO QUALITY BENCHMARKING RATINGS

A FACT-BASED APPROACH TO YOUR

CRO PROVIDER SELECTION

Which CRO is the best to conduct a given trial? Who will perform the best?

Industry Standard Research asked biopharma and pharmaceutical executives from North America, Europe and Asia to rate 40+ Phase I-III CRO providers on staff, delivery, budget, loyalty and more.

REQUEST YOUR COMPLIMENTARY EXECUTIVE SUMMARY

Phase I Service Providers (12th Edition)
PHASE II/III SERVICE PROVIDERS (12TH EDITION)

Get The Executive Summary

Fill out the brief form to take a fact-based approach to choosing your clinical development partner with the 2020 ISR Reports.

WORLDWIDE IS THE ONLY CRO RATED A TOP PERFORMER
FOR STAFF, DELIVERY, BUDGET AND LOYALTY ACROSS
PHASE I-III CRO SERVICES

STAFF CHARACTERISTICS

  • Project manager quality
  • Responsiveness
  • Staff turnover
  • Study design expertise
  • Therapeutic expertise
  • Timely project communications

DELIVERY FACTORS

  • Data quality
  • Easy to work with
  • Local market/regulatory knowledge
  • Meeting overall project timelines
  • Operational excellence
  • Patient/volunteer recruitment
  • Technology for real-time access to data

BUDGET FACTORS

  • Appropriateness of change orders
  • Cost

LOYALTY METRICS

  • Likelihood to recommend
  • Likelihood to use again
  • Overall satisfaction

CUSTOMER FEEDBACK

Great experience.
Very supportive and responsive staff.”
We had a NIHfunded trial, with rigorous and abnormally complex standards.
Worldwide patiently helped us with the process and was constantly available.”
Responsive and operational excellence is solid.”
Worldwide offers risk mitigation activities, new solutions and quick startup time.”
Excellent communication.”
Worldwide’s Data Management is the best in the industry.”
Worldwide has come through for my company with expedited timelines to make sure we were able to meet last-minute principal investigator requirements prior to new drug application submission.”
Well run.”
Good value, expertise and technology.”
Worldwide has greatly exceeded my expectations.”

Source: Industry Standard Research, 2020. CRO Quality Benchmarking – Phase I Service Providers (12th Edition), CRO Quality Benchmarking – Phase II/III Service Providers (12th Edition)

RATING METHODOLOGY

As rated by customers for Phase I-III CRO services Respondents were required to pass several screening criteria to qualify and participate in this survey:

  • Must work at a pharmaceutical company, biotech company, or medical device company
  • Must have responsibility in at least one of several relevant areas such as Clinical Operations, Project Management, Executive Management, or Research and Development Management
  • Must have involvement with outsourced Phase I-III trials within past 12 months

REQUEST YOUR COMPLIMENTARY EXECUTIVE SUMMARY

Phase I Service Providers (12th Edition)
PHASE II/III SERVICE PROVIDERS (12TH EDITION)